Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.44 Billion CNY | 12.87% |
| 2022 | 2.19 Billion CNY | 12.06% |
| 2021 | 1.95 Billion CNY | 0.39% |
| 2020 | 1.94 Billion CNY | 7.96% |
| 2019 | 1.8 Billion CNY | 43.18% |
| 2018 | 1.26 Billion CNY | 38.85% |
| 2017 | 907.82 Million CNY | 27.66% |
| 2016 | 711.11 Million CNY | 25.91% |
| 2015 | 564.78 Million CNY | 12.81% |
| 2014 | 500.64 Million CNY | 25.58% |
| 2013 | 398.66 Million CNY | 30.79% |
| 2012 | 304.81 Million CNY | 34.41% |
| 2011 | 226.78 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 549.43 Million CNY | -22.34% |
| 2024 Q3 | 611.43 Million CNY | 13.63% |
| 2024 Q1 | 707.48 Million CNY | 15.29% |
| 2023 Q3 | 633.66 Million CNY | 8.73% |
| 2023 Q1 | 644.14 Million CNY | 26.49% |
| 2023 Q2 | 582.76 Million CNY | -9.53% |
| 2023 Q4 | 613.65 Million CNY | -3.16% |
| 2023 FY | 2.47 Billion CNY | 12.87% |
| 2022 Q3 | 579.09 Million CNY | 11.17% |
| 2022 Q1 | 582.8 Million CNY | 39.59% |
| 2022 FY | 2.19 Billion CNY | 12.06% |
| 2022 Q4 | 509.23 Million CNY | -12.06% |
| 2022 Q2 | 520.91 Million CNY | -10.62% |
| 2021 Q3 | 547.12 Million CNY | 16.43% |
| 2021 Q1 | 521.58 Million CNY | 10.91% |
| 2021 FY | 1.95 Billion CNY | 0.39% |
| 2021 Q2 | 469.93 Million CNY | -9.9% |
| 2021 Q4 | 417.49 Million CNY | -23.69% |
| 2020 Q3 | 528.35 Million CNY | 7.33% |
| 2020 Q4 | 470.26 Million CNY | -10.99% |
| 2020 FY | 1.94 Billion CNY | 7.96% |
| 2020 Q1 | 457.76 Million CNY | 6.3% |
| 2020 Q2 | 492.25 Million CNY | 7.53% |
| 2019 Q3 | 501.92 Million CNY | 7.8% |
| 2019 Q2 | 465.6 Million CNY | 14.47% |
| 2019 Q1 | 406.72 Million CNY | 11.54% |
| 2019 FY | 1.8 Billion CNY | 43.18% |
| 2019 Q4 | 430.64 Million CNY | -14.2% |
| 2018 Q4 | 364.63 Million CNY | 10.02% |
| 2018 Q3 | 331.43 Million CNY | 9.22% |
| 2018 FY | 1.26 Billion CNY | 38.85% |
| 2018 Q2 | 303.46 Million CNY | 16.26% |
| 2018 Q1 | 261.01 Million CNY | 5.75% |
| 2017 Q2 | 219.28 Million CNY | 8.81% |
| 2017 Q4 | 246.82 Million CNY | 2.76% |
| 2017 FY | 907.82 Million CNY | 27.66% |
| 2017 Q1 | 201.52 Million CNY | -0.18% |
| 2017 Q3 | 240.18 Million CNY | 9.53% |
| 2016 Q3 | 176.16 Million CNY | 4.82% |
| 2016 FY | 711.11 Million CNY | 25.91% |
| 2016 Q4 | 201.87 Million CNY | 14.59% |
| 2016 Q2 | 168.07 Million CNY | 1.87% |
| 2016 Q1 | 164.99 Million CNY | 17.8% |
| 2015 Q3 | 152.31 Million CNY | 7.94% |
| 2015 FY | 564.78 Million CNY | 12.81% |
| 2015 Q1 | 131.28 Million CNY | -3.31% |
| 2015 Q2 | 141.11 Million CNY | 7.48% |
| 2015 Q4 | 140.06 Million CNY | -8.05% |
| 2014 Q3 | 127.7 Million CNY | 2.08% |
| 2014 Q4 | 135.79 Million CNY | 6.33% |
| 2014 FY | 500.64 Million CNY | 25.58% |
| 2014 Q2 | 125.1 Million CNY | 11.65% |
| 2014 Q1 | 112.04 Million CNY | 7.25% |
| 2013 Q3 | 113.47 Million CNY | 0.0% |
| 2013 FY | 398.66 Million CNY | 30.79% |
| 2013 Q4 | 104.47 Million CNY | -7.93% |
| 2012 FY | 304.81 Million CNY | 34.41% |
| 2011 FY | 226.78 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 4.38 Billion CNY | 44.296% |
| Liaoning Cheng Da Co., Ltd. | 1.28 Billion CNY | -89.475% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 30.92 Billion CNY | 92.105% |